Articaine HCl

CAS No. 23964-57-0

Articaine HCl( Carticaine | HOE 045 | HOE 40045 )

Catalog No. M13691 CAS No. 23964-57-0

Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 34 In Stock
50MG 49 In Stock
100MG 82 In Stock
200MG 127 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Articaine HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
  • Description
    Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Carticaine | HOE 045 | HOE 40045
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    23964-57-0
  • Formula Weight
    320.84
  • Molecular Formula
    C13H21ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C(C1=C(NC(C(NCCC)C)=O)C(C)=CS1)OC.[H]Cl
  • Chemical Name
    Methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate Hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oertel R, et al. Clin Pharmacokinet, 1997, 33(6), 417-425.
molnova catalog
related products
  • Benzamil (hydrochlor...

    Benzamil is an epithelial sodium channel (ENaC) blocker that inhibits sodium transport from (IC50 = 4 nM) and binds to (Kd = 5 nM) bovine kidney cortex membrane vesicles.

  • Zandatrigine

    Zandatrigine (NBI-921352) is a sodium channel protein type 8 subunit alpha blocker, suitable for studies on epilepsy treatment and nervous system pathologies.

  • PF-06305591

    PF-06305591 (PF06305591) is a potent, highly selective selective NaV1.8 blocker with IC50 of 15 nM, displays no significant activity against other sodium channel subtypes, K+ channels and Ca2+ channels.